New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
05:50 EDTGRPN, TEVAStocks with implied volatility movement; GRPN TEVA
Stocks with implied volatility movement; Groupon (GRPN) 68, Teva (TEVA) 33 according to iVolatility.
News For GRPN;TEVA From The Last 14 Days
Check below for free stories on GRPN;TEVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
09:25 EDTGRPNGroupon expands Deal Builder tool for merchants
Subscribe for More Information
September 19, 2014
09:22 EDTGRPNGroupon has several upcoming catalysts, says Sterne Agee
Subscribe for More Information
September 17, 2014
11:01 EDTTEVAActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
08:05 EDTTEVAEagle Pharm says Teva requests motion to dismiss Bendamustine lawsuit
Subscribe for More Information
September 12, 2014
09:01 EDTTEVATeva to present Copaxone gene expression analysis
Subscribe for More Information
08:06 EDTTEVATeva presents new clinical safety data in RRMS patients treated with Laquinimod
Teva (TEVA) and Active Biotech (ACTI) announced new follow-up data evaluating the clinical safety of laquinimod in patients with relapsing-remitting multiple sclerosis, or RRMS, who were treated with laquinimod in Phase II, Phase III and open-label extension studies for two or more years. The pooled safety analysis of the Phase II LAQ/5063 and the Phase III ALLEGRO and BRAVO extension studies supports findings observed in the core studies where currently identified risks were observed within the first months of laquinimod treatment. In the pooled safety analysis, rates of adverse events, or AEs, and serious AEs were lower in the open-label extensions than in the core studies and less than three percent of patients discontinued treatment due to AEs during these extensions. Additionally, shifts to potentially significant laboratory values were considerably lower in patients exposed to at least two years of laquinimod.
08:03 EDTTEVATeva, Active Biotech present laquinimod follow-up data
Subscribe for More Information
September 11, 2014
09:31 EDTTEVATeva announces new data from Phase IIIb GLACIER study
Subscribe for More Information
03:27 EDTTEVATeva Canada announces launch of generic version of Cipralex
Subscribe for More Information
September 10, 2014
14:25 EDTTEVATeva Canada announces launch of generic version of Cipralex
Subscribe for More Information
September 9, 2014
15:11 EDTGRPNGroupon confirms integration with Apple Pay
Groupon (GRPN) announced its integration with Apple Pay, Apple's (AAPL) new mobile payment system for iPhone 6 and iPhone 6 Plus. Groupon said it is one of the first mobile commerce companies to announce integration with Apple Pay, and the new payment option will be available to customers beginning in October.
13:58 EDTGRPNStarbucks, Groupon, OpenTable apps among those to integrate Apple Pay
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use